| For: | Niu ZS, Niu XJ, Wang WH. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. World J Gastroenterol 2017; 23(32): 5860-5874 [PMID: 28932078 DOI: 10.3748/wjg.v23.i32.5860] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i32/5860.htm |
| Number | Citing Articles |
| 1 |
Jianbing Wu, Xiaoxin Zhou, Yilei Fan, Xiangwei Cheng, Bin Lu, Zhe Chen. Long non-coding RNA 00312 downregulates cyclin B1 and inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo. Biochemical and Biophysical Research Communications 2018; 497(1) doi: 10.1016/j.bbrc.2018.02.049
|
| 2 |
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022; 9(8) doi: 10.3390/bioengineering9080406
|
| 3 |
Raed Obaid Saleh, Hamad Ali Hamad, Maryam Abdulrahman Najim, Soumya V. Menon, Mandeep Kaur, G. V. Sivaprasad, Mohammad Abohassan, Wen-Tau Juan, Beneen Husseen, Yasser Fakri Mustafa. RETRACTED ARTICLE: Exosome-mediated Transfer of lncRNA in Liver Associated Diseases; Uncovered Truths. Cell Biochemistry and Biophysics 2024; 83(2) doi: 10.1007/s12013-024-01617-x
|
| 4 |
Wei Zhang, Songyang Liu, Kai Liu, Yahui Liu. Long non‐coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR‐133a to regulate IGF‐1R expression. Journal of Cellular and Molecular Medicine 2019; 23(8) doi: 10.1111/jcmm.14384
|
| 5 |
Wenjing Xiao, Dezhi Zheng, Xin Chen, Botao Yu, Kaiwen Deng, Jie Ma, Xudong Wen, Yonghe Hu, Jun Hou. Long non-coding RNA MIAT is involved in the regulation of pyroptosis in diabetic cardiomyopathy via targeting miR-214-3p. iScience 2021; 24(12) doi: 10.1016/j.isci.2021.103518
|
| 6 |
Hyun Jin Jung, Hyun-Ju Kim, Kwan-Kyu Park. Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis. International Journal of Molecular Sciences 2020; 21(8) doi: 10.3390/ijms21082698
|
| 7 |
Min Hao, Jinling Zan, Hafiz Ishfaq Ahmad. The Identification of Childhood Asthma Progression-Related lncRNAs and mRNAs Suitable as Biomarkers Using Weighted Gene Coexpression Network Analysis. Genetics Research 2021; 2021 doi: 10.1155/2021/5511507
|
| 8 |
Shengwei Tao, Shuhang Liang, Taofei Zeng, Dalong Yin. Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1043667
|
| 9 |
Jialu Liang, Minghao Zhou, Mingyi Xie, Qianqian Song. ShapeRNA: an integrated web server for RNA secondary structure, ensemble, and functional analysis. Nucleic Acids Research 2026; 54(W1) doi: 10.1093/nar/gkag387
|
| 10 |
Fang Guo, Yun-Zhi Chen, Liu Li, Cong Chen, Jian-Hua Jin, Jie Yang, Jing-Jing Chen, Xin-Yan Chen, Min Guo, Yu-Mei Chen. Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis. Biomedicine & Pharmacotherapy 2018; 98 doi: 10.1016/j.biopha.2017.11.143
|
| 11 |
Bin Wang, Xiangpan Li, Wenjuan Hu, Yu Zhou, Youming Din. Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization. IUBMB Life 2019; 71(12) doi: 10.1002/iub.2137
|
| 12 |
Young-Ah Kim, Kwan-Kyu Park, Sun-Jae Lee. LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(8) doi: 10.3390/ijms21082883
|
| 13 |
Edie-Rosmin Wu, Ying-Erh Chou, Yu-Fan Liu, Kuan-Chun Hsueh, Hsiang-Lin Lee, Shun-Fa Yang, Shih-Chi Su. Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma. Genes 2019; 10(7) doi: 10.3390/genes10070506
|
| 14 |
Yu Li, Gang Liu, Xiaojun Li, Huiyuan Dong, Weike Xiao, Shaokang Lu. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochemical and Biophysical Research Communications 2018; 503(4) doi: 10.1016/j.bbrc.2018.08.047
|
| 15 |
Le Lu, Yufan Wu, Min Feng, Xiaofeng Xue, Yuan Fan. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10665
|
| 16 |
Xiaohong Zhang, Jian Li, Fan Li, Zhen Zhao, Li Feng. LINC00682 inhibits gastric cancer cell progression via targeting microRNA-9-LMX1A signaling axis. Aging 2019; 11(23) doi: 10.18632/aging.102533
|
| 17 |
Humin Chen, Liang Guo. Exercise in Diabetic Cardiomyopathy: Its Protective Effects and Molecular Mechanism. International Journal of Molecular Sciences 2025; 26(4) doi: 10.3390/ijms26041465
|
| 18 |
Ge Yang, Yang Fu, Xiaoyan Lu, Menghua Wang, Hongtao Dong, Qiuming Li. LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells. Journal of Cellular and Molecular Medicine 2018; 22(10) doi: 10.1111/jcmm.13796
|
| 19 |
Jin-qian Liang, Zhen-tao Zhou, Lin Bo, Hai-ning Tan, Jian-hua Hu, Ming-sheng Tan. Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone through activation of Nrf2 signaling cascade. Cell Death & Disease 2021; 12(11) doi: 10.1038/s41419-021-04250-1
|
| 20 |
Deyu Huang, Chunhua Bi, Qingxi Zhao, Xueli Ding, Cheng Bian, Hui Wang, Ting Wang, Hua Liu. RETRACTED ARTICLE: Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4831-6
|
| 21 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20) doi: 10.1158/0008-5472.CAN-19-0255
|
| 22 |
Gao Liu, Zhang-Fu Yang, Jian Sun, Bao-Ye Sun, Pei-Yun Zhou, Cheng Zhou, Ruo-Yu Guan, Zhu-Tao Wang, Yong Yi, Shuang-Jian Qiu. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. Cellular Oncology 2022; 45(6) doi: 10.1007/s13402-022-00730-4
|
| 23 |
Hui Ling, Xian-Chen Wang, Zhi-Yan Liu, Sui Mao, Jing-Jing Yang, Ji-Ming Sha, Hui Tao. Noncoding RNA network crosstalk in organ fibrosis. Cellular Signalling 2024; 124 doi: 10.1016/j.cellsig.2024.111430
|
| 24 |
Weizheng Liang, Yan Zhao, Qingxue Meng, Wenjie Jiang, Shoulong Deng, Jun Xue. The role of long non-coding RNA in hepatocellular carcinoma. Aging 2024; 16(4) doi: 10.18632/aging.205523
|
| 25 |
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.583714
|
| 26 |
Yingying Zhang, Hongyu Zhang, Shuhuan Wu. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S306484
|
| 27 |
Shimaa E. Soliman, Abdel Monem A. ElTorgoman, Mohamed F.A. Assar, Naglaa S. El Abd, Suzy F. Gohar, Raouth E. Girgis. Biochemical and molecular study of long non-coding RNAs (HOTTIP, ZEB-AS1 and MEG-3) in hepatocellular carcinoma. Meta Gene 2020; 26 doi: 10.1016/j.mgene.2020.100808
|
| 28 |
Huojian Shen, Hongyi Zhu, Yuanwen Chen, Zhiyong Shen, Weiqing Qiu, Changlin Qian, Jie Zhang. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression. Cell Death & Disease 2021; 12(4) doi: 10.1038/s41419-021-03571-5
|
| 29 |
Ning Wang, Fei-Tian Min, Wei-Bo Wen, Huan-Tian Cui. Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA. World Journal of Gastroenterology 2025; 31(21): 103184 doi: 10.3748/wjg.v31.i21.103184
|
| 30 |
Harpreet Kaur, Sherry Bhalla, Gajendra P. S. Raghava, Ernest K. Amankwah. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. PLOS ONE 2019; 14(9) doi: 10.1371/journal.pone.0221476
|
| 31 |
Liping Zhong, Xiuwen Zhong. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1975019
|
| 32 |
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 2019; 204 doi: 10.1016/j.trsl.2018.09.001
|
| 33 |
Durmuş Ayan, Şerife Buket Bozkurt Polat, Ergül Bayram, Esma Özmen, Fatma Esin Aydın, Serpil Ersan. A Comparative Analysis of the Roles of von Willebrand Factor and ADAMTS13 in Hepatocellular Carcinoma: A Bioinformatics and Microarray-Based Study. Current Issues in Molecular Biology 2025; 47(4) doi: 10.3390/cimb47040270
|
| 34 |
Ying Wu, Peng‐Shuo Wang, Ben‐Gang Wang, Lu Xu, Wan‐Xia Fang, Xiao‐Fang Che, Xiu‐Juan Qu, Yun‐Peng Liu, Zhi Li. Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma. Cancer Medicine 2018; 7(12) doi: 10.1002/cam4.1854
|
| 35 |
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research 2020; 160 doi: 10.1016/j.phrs.2020.105195
|
| 36 |
Tiago Falcon, Martiela Freitas, Ana Carolina Mello, Laura Coutinho, Mario R. Alvares-da-Silva, Ursula Matte. Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma. BioMed Research International 2018; 2018 doi: 10.1155/2018/2864120
|
| 37 |
Yan Lv, Yin Wang, Yu Song, Shu-Sheng Wang, Kai-wen Cheng, Zhi-qing Zhang, Jin Yao, Li-na Zhou, Zhuo-yan Ling, Cong Cao. LncRNA PINK1-AS promotes Gαi1-driven gastric cancer tumorigenesis by sponging microRNA-200a. Oncogene 2021; 40(22) doi: 10.1038/s41388-021-01812-7
|
| 38 |
Behnam Alipoor, Seyedeh Nasrin Parvar, Zolfaghar Sabati, Hamid Ghaedi, Hassan Ghasemi. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. Molecular Biology Reports 2020; 47(8) doi: 10.1007/s11033-020-05695-x
|
| 39 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308 doi: 10.1016/j.lfs.2022.120974
|
| 40 |
Zhanpeng Wang, Lina Song, Yanshuo Ye, Wei Li. <p>Long Noncoding RNA DIO3OS Hinders Cell Malignant Behaviors of Hepatocellular Carcinoma Cells Through the microRNA-328/Hhip Axis</p>. Cancer Management and Research 2020; doi: 10.2147/CMAR.S245990
|
| 41 |
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, Archna Dhasmana, Fulden Ulucan-Karnak, Sara Sargazi, Saman Sargazi, Sonia Fathi-Karkan, Abbas Rahdar. Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer. Nanoscale 2024; 16(8) doi: 10.1039/D3NR05656B
|
| 42 |
Yufeng Wang, Zhencun Yang, Liang Wang, Liankang Sun, Zhikui Liu, Qing Li, Bowen Yao, Tianxiang Chen, Cong Wang, Wei Yang, Qingguang Liu, Shaoshan Han. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomedicine & Pharmacotherapy 2019; 109 doi: 10.1016/j.biopha.2018.10.145
|
| 43 |
Mohamed H. Yousef, Hassan A. N. El-Fawal, Anwar Abdelnaser, Junyan Tao. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/9593254
|
| 44 |
Zhongju Shi, Bin Pan, Shiqing Feng. The emerging role of long non‐coding RNA in spinal cord injury. Journal of Cellular and Molecular Medicine 2018; 22(4) doi: 10.1111/jcmm.13515
|
| 45 |
Zichen Xie, Heng Zhang, Jiqin Wang, Zhimin Li, Chao Qiu, Keyu Sun. LIN28B-AS1-IGF2BP1 association is required for LPS-induced NFκB activation and pro-inflammatory responses in human macrophages and monocytes. Biochemical and Biophysical Research Communications 2019; 519(3) doi: 10.1016/j.bbrc.2019.09.012
|
| 46 |
Aiyao Wang, Jun Meng, Hui Liu, Chen Li, Zhiyong Zhou. Long non‑coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion. Oncology Letters 2020; 20(3) doi: 10.3892/ol.2020.11826
|
| 47 |
Yongping Zhou, Yonggang Huang, Tu Dai, Zhiyuan Hua, Jian Xu, Yuting Lin, Lulu Han, Xiong Yue, Lichen Ho, Jinjing Lu, Xiaoming Ai. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Biomedicine & Pharmacotherapy 2021; 133 doi: 10.1016/j.biopha.2020.111030
|
| 48 |
Li Feng, Huanqin Li, Fan Li, Songhua Bei, Xiaohong Zhang. LncRNA KCNQ1OT1 regulates microRNA-9-LMX1A expression and inhibits gastric cancer cell progression. Aging 2020; 12(1) doi: 10.18632/aging.102651
|
| 49 |
Jian Zhang, Kewei Hu, Yong-qiang Yang, Yin Wang, Yu-fan Zheng, Yong Jin, Ping Li, Long Cheng. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression. Cell Death & Disease 2020; 11(9) doi: 10.1038/s41419-020-02967-z
|
| 50 |
Kevin Park, Mysore S. Veena, Daniel Sanghoon Shin. Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.830208
|
| 51 |
Hao Wu, Tian Tian Liu, Yue Min Feng, Xiao Yu Xie, Xiao Nan Su, Jian Ni Qi, Qiang Zhu, Cheng Yong Qin. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus‐related hepatocellular carcinoma after hepatectomy. Journal of Digestive Diseases 2020; 21(11) doi: 10.1111/1751-2980.12941
|
| 52 |
Guijun He, Wenfeng Yao, Liang Li, Yang Wu, Guojian Feng, Li Chen. LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01565-5
|
| 53 |
Zihao Fan, Hao Pan, Na Qu, Xin Wang, Lianrui Cao, Lijiang Chen, Mingxia Liu. LncRNA taurine upregulated gene 1 in liver disease. Clinica Chimica Acta 2024; 560 doi: 10.1016/j.cca.2024.119752
|